Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novan Inc (NQ: NOVN ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Novan Inc Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection July 17, 2023 From Novan, Inc. Via GlobeNewswire Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders June 05, 2023 From Novan, Inc. Via GlobeNewswire Novan Focuses Strategic Direction and Announces Restructuring May 31, 2023 From Novan, Inc. Via GlobeNewswire Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update May 15, 2023 From Novan, Inc. Via GlobeNewswire Novan to Report First Quarter 2023 Financial Results on May 15, 2023 May 08, 2023 From Novan, Inc. Via GlobeNewswire Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹ April 27, 2023 From Novan, Inc. Via GlobeNewswire Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD April 20, 2023 Live moderated webcast with members of the Novan management team and dermatological key opinion leader, Dr. Jeffrey Sugarman on Tuesday, April 25th at 2:00 PM ET From Novan, Inc. Via GlobeNewswire Novan Reports Full Year 2022 Financial Results and Provides Corporate Update March 30, 2023 From Novan, Inc. Via GlobeNewswire Novan to Report Full Year 2022 Financial Results on March 30, 2023 March 23, 2023 From Novan, Inc. Via GlobeNewswire Novan Announces Closing of $6.0 Million Registered Direct Offering March 16, 2023 From Novan, Inc. Via GlobeNewswire Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference March 14, 2023 Presentation with live webcast today, March 14th at 10:40 AM ET From Novan, Inc. Via GlobeNewswire Novan Announces $6.0 Million Registered Direct Offering March 14, 2023 From Novan, Inc. Via GlobeNewswire Novan Moves Forward with Unified Corporate Branding March 08, 2023 From Novan, Inc. Via GlobeNewswire FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024 March 07, 2023 From Novan, Inc. Via GlobeNewswire Novan to Present at the Virtual Investor 2023 Companies to Watch Event January 18, 2023 Live video webcast on Thursday, January 19th at 12:00 PM ET From Novan, Inc. Via GlobeNewswire JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th January 11, 2023 Via ACCESSWIRE Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum January 06, 2023 From Novan, Inc. Via GlobeNewswire EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan December 21, 2022 From Novan, Inc. Via GlobeNewswire EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement December 02, 2022 From Novan, Inc. Via GlobeNewswire Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference December 01, 2022 From Novan, Inc. Via GlobeNewswire Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update November 14, 2022 From Novan, Inc. Via GlobeNewswire Novan to Report Third Quarter 2022 Financial Results on November 14, 2022 November 07, 2022 From Novan, Inc. Via GlobeNewswire EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 Research shows PAD (Polyaphron Dispersion) Technology™ leads to more efficient delivery of Calcipotriene (CAL) and Betamethasone Dipropionate (BDP) than CAL/BDP topical suspension From Novan, Inc. Via GlobeNewswire EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference® October 21, 2022 Data collected shows importance of treatment formulation characteristics and speed of improvement in psoriasis symptoms to patient treatment adherence From Novan, Inc. Via GlobeNewswire Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference® October 14, 2022 From Novan, Inc. Via GlobeNewswire JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th November 04, 2021 - Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating... From JTC Team, LLC Via AccessWire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.